Silverman Joshua reported grant involving 4,375,000 shares of Petros Pharmaceuticals, Inc. at $0.00 for $0 on Jun 5, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
4,375,000Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
8,790,450Direct
Trade date
Jun 5, 2026Grant
Filed
Jun 5, 2026, 5:12 PM ET0-day reporting delay
Accession
0001104659-26-071038Code A · Transaction 99275
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PTPI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTPI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d 0%30d 0%90d180d1y

Footnotes in full

F1: Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date.